Literature DB >> 24975622

Quantitative EEG neurofeedback for the treatment of pediatric attention-deficit/hyperactivity disorder, autism spectrum disorders, learning disorders, and epilepsy.

Elizabeth Hurt1, L Eugene Arnold2, Nicholas Lofthouse3.   

Abstract

Neurofeedback (NF) using surface electroencephalographic signals has been used to treat various child psychiatric disorders by providing patients with video/audio information about their brain's electrical activity in real-time. Research data are reviewed and clinical recommendations are made regarding NF treatment of youth with attention deficit/hyperactivity disorder, autism, learning disorders, and epilepsy. Most NF studies are limited by methodological issues, such as failure to use or test the validity of a full-blind or sham NF. The safety of NF treatment has not been thoroughly investigated in youth or adults, although clinical experience suggests reasonable safety.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADHD; Autism spectrum disorders; EEG biofeedback; Epilepsy; Learning disorders; Neurofeedback; Neurotherapy; Quantitative EEG

Mesh:

Year:  2014        PMID: 24975622     DOI: 10.1016/j.chc.2014.02.001

Source DB:  PubMed          Journal:  Child Adolesc Psychiatr Clin N Am        ISSN: 1056-4993


  13 in total

1.  Neurofeedback impacts cognition and quality of life in pediatric focal epilepsy: An exploratory randomized double-blinded sham-controlled trial.

Authors:  Leon Morales-Quezada; Diana Martinez; Mirret M El-Hagrassy; Ted J Kaptchuk; M Barry Sterman; Gloria Y Yeh
Journal:  Epilepsy Behav       Date:  2019-11-08       Impact factor: 2.937

Review 2.  Cognitive and Behavioral Interventions in Epilepsy.

Authors:  Beth A Leeman-Markowski; Steven C Schachter
Journal:  Curr Neurol Neurosci Rep       Date:  2017-05       Impact factor: 5.081

Review 3.  Are treatment effects of neurofeedback training in children with ADHD related to the successful regulation of brain activity? A review on the learning of regulation of brain activity and a contribution to the discussion on specificity.

Authors:  Agnieszka Zuberer; Daniel Brandeis; Renate Drechsler
Journal:  Front Hum Neurosci       Date:  2015-03-27       Impact factor: 3.169

4.  Neurofeedback: A Comprehensive Review on System Design, Methodology and Clinical Applications.

Authors:  Hengameh Marzbani; Hamid Reza Marateb; Marjan Mansourian
Journal:  Basic Clin Neurosci       Date:  2016-04

5.  A Randomized Controlled Study of Neurofeedback for Chronic PTSD.

Authors:  Bessel A van der Kolk; Hilary Hodgdon; Mark Gapen; Regina Musicaro; Michael K Suvak; Ed Hamlin; Joseph Spinazzola
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

Review 6.  Tuning Up the Old Brain with New Tricks: Attention Training via Neurofeedback.

Authors:  Yang Jiang; Reza Abiri; Xiaopeng Zhao
Journal:  Front Aging Neurosci       Date:  2017-03-13       Impact factor: 5.750

7.  The Treatment of Autism Spectrum Disorder With Auditory Neurofeedback: A Randomized Placebo Controlled Trial Using the Mente Autism Device.

Authors:  Frederick R Carrick; Guido Pagnacco; Ahmed Hankir; Mahera Abdulrahman; Rashid Zaman; Emily R Kalambaheti; Derek A Barton; Paul E Link; Elena Oggero
Journal:  Front Neurol       Date:  2018-07-05       Impact factor: 4.003

8.  Neurofeedback Treatment of Negative Symptoms in Schizophrenia: Two Case Reports.

Authors:  Khashayar Pazooki; Max Leibetseder; Walter Renner; Gabriel Gougleris; Efsevia Kapsali
Journal:  Appl Psychophysiol Biofeedback       Date:  2019-03

9.  Emotion Regulation Using Virtual Environments and Real-Time fMRI Neurofeedback.

Authors:  Valentina Lorenzetti; Bruno Melo; Rodrigo Basílio; Chao Suo; Murat Yücel; Carlos J Tierra-Criollo; Jorge Moll
Journal:  Front Neurol       Date:  2018-07-24       Impact factor: 4.003

Review 10.  Pathogenetical and Neurophysiological Features of Patients with Autism Spectrum Disorder: Phenomena and Diagnoses.

Authors:  Yunho Jin; Jeonghyun Choi; Seunghoon Lee; Jong Won Kim; Yonggeun Hong
Journal:  J Clin Med       Date:  2019-10-02       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.